Exclusive

Publication

Byline

Location

US Patent Issued to TriviumVet DAC on April 14 for "Veterinary formulations comprising rapamycin and methods of using the same for treating animal disease" (Irish Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,590, issued on April 14, was assigned to TriviumVet DAC (Waterford, Ireland). "Veterinary formulations comprising rapamycin and methods of... Read More


US Patent Issued to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, THE TEXAS A&M UNIVERSITY SYSTEM on April 14 for "Therapeutic small molecules for treatment of pulmonary hypertension" (Pennsylvania, Texas Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,592, issued on April 14, was assigned to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh) and THE TEXAS... Read More


US Patent Issued to Amicus Therapeutics on April 14 for "Treatment of Fabry disease in ERT-naive and ERT-experienced patients" (Pennsylvania Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,594, issued on April 14, was assigned to Amicus Therapeutics Inc. (Philadelphia). "Treatment of Fabry disease in ERT-naive and ERT-experie... Read More


US Patent Issued to Shanghai Hui Tian Jin Ze Biotech on April 14 for "Anti-tumor pharmaceutical composition based on immune checkpoint blockade and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,596, issued on April 14, was assigned to Shanghai Hui Tian Jin Ze Biotech Co. Ltd. (Shanghai). "Anti-tumor pharmaceutical composition base... Read More


US Patent Issued to AUSPEX PHARMACEUTICALS on April 14 for "Osmotic dosage forms comprising deutetrabenazine and methods of use thereof" (Florida, New Jersey Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,598, issued on April 14, was assigned to AUSPEX PHARMACEUTICALS LLC (Parsippany, N.J.). "Osmotic dosage forms comprising deutetrabenazine ... Read More


US Patent Issued to Arizona Board of Regents on Behalf of the University of Arizona, University of Washington on April 14 for "Compositions and methods for preventing and treating headache through enhancing 2-arachydonyl glyerol activity" (Arizona, Washington Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,600, issued on April 14, was assigned to Arizona Board of Regents on Behalf of the University of Arizona (Tucson, Ariz.) and University of ... Read More


US Patent Issued to Mirum Pharmaceuticals on April 14 for "Methods for treating cholestasis" (American, Swiss Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,602, issued on April 14, was assigned to Mirum Pharmaceuticals Inc.. "Methods for treating cholestasis" was invented by Thomas Jaecklin (D... Read More


US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS on April 14 for "Application of JAK inhibitor in kidney disease" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,604, issued on April 14, was assigned to JIANGSU HENGRUI PHARMACEUTICALS Co. LTD. (Lianyungang, China). "Application of JAK inhibitor in k... Read More


US Patent Issued to Janssen Biotech, Yuhan on April 14 for "Therapies with 3rd generation EGFR tyrosine kinase inhibitors" (South Korean Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,606, issued on April 14, was assigned to Janssen Biotech Inc. (Horsham, Pa.) and Yuhan Corp. (Seoul, South Korea). "Therapies with 3rd gen... Read More


US Patent Issued to The Regents of the University of California, The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Gladstone on April 14 for "Methods for treating cardiac valve disease" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,608, issued on April 14, was assigned to The Regents of the University of California (Oakland, Calif.) and The J. David Gladstone Institute... Read More